Biogen Inc. buy Robert W. Baird
Start price
14.02.24
/
50%
€206.60
Target price
14.02.25
€294.45
Performance (%)
-11.86%
Price
11:10
€182.10
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.86%. This prediction currently runs until 14.02.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -1.914% | -1.914% |
iShares Core DAX® | -1.611% | 3.135% |
iShares Nasdaq 100 | -0.500% | 0.775% |
iShares Nikkei 225® | -1.483% | 4.610% |
iShares S&P 500 | -0.501% | 1.914% |
Comments by Robert_W__Baird for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Robert W. Baird from $333.00 to $316.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat